<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00265512</url>
  </required_header>
  <id_info>
    <org_study_id>IIR 05-021</org_study_id>
    <nct_id>NCT00265512</nct_id>
  </id_info>
  <brief_title>LINK: Aftercare Monitoring Project</brief_title>
  <official_title>Improving Longterm SUD Outcomes With Telephone Case Monitoring</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>VA Office of Research and Development</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>VA Office of Research and Development</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The prevalence of substance use disorders (SUD) in the VA is rising, making SUD(s) among the
      most commonly diagnosed disorders in the VA. A substantial body of data attests to the
      effectiveness of substance use disorder treatment; further the predictor most consistently
      associated with positive addiction treatment outcomes is duration. Despite the body of
      evidence supporting length of treatment as one of the stronger predictors of long-term SUD
      outcomes, only 36% of SUD treatment programs in the VA are meeting the continuing care
      performance criterion specified by the Office of Quality Performance. This randomized
      clinical trial investigates whether substance use disorder patients assigned to telephone
      case monitoring (TCM) for continuing care will do better than those attending face-to-face
      continuing care as usual (CCAU)(standard outpatient care).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Background: The prevalence of substance use disorders (SUD) in the VA is rising, making
      SUD(s) among the most commonly diagnosed disorders in the VA. A substantial body of data
      attests to the effectiveness of substance use disorder treatment; further the predictor most
      consistently associated with positive addiction treatment outcomes is duration. Despite the
      body of evidence supporting length of treatment as one of the stronger predictors of
      long-term SUD outcomes, only 36% of SUD treatment programs in the VA are meeting the
      continuing care performance criterion specified by the Office of Quality Performance. The
      proposed randomized clinical trial investigates whether substance use disorder patients
      assigned to telephone case monitoring (TCM) for continuing care will do better than those
      attending face-to-face continuing care as usual (CCAU)(standard outpatient care).

      Objectives: The objective of this research is to test, in a randomized clinical trial,
      whether in-person CCAU following intensive outpatient SUD treatment leads to better SUD
      outcomes when compared with TCM. In addition, we will investigate whether continuing care
      condition interacts with distance from providers such that telephone case monitoring (TCM)
      produces increasingly stronger results relative to continuing care as usual (CCAU) as
      distance from care increases. Should we find an interaction, we will test whether the
      interaction is due to TCM producing better proximal outcomes such as level of participation
      in continuing care and satisfaction with treatment. Finally, we will investigate the cost of
      providing telephone care relative to continuing care as usual.

      Methods: The design of this study is a randomized controlled trial of telephone case
      monitoring versus face-to-face continuing care as usual with 2 sites and up to 500 patients
      per site recruited over 1.5 years for a total of up to 1000 patients. Patients will be
      involved in the intervention for up to 6 months and data collection will occur at baseline,
      3, 6 and 12 months via mailed surveys. Data of interest include self-report of substance use,
      psychiatric symptoms, and quality of life. Data analyses will be conducted using hierarchical
      linear modeling.

      Status: Patient recruitment has ended. Treatment and follow-up are on-going.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2006</start_date>
  <completion_date type="Actual">January 2010</completion_date>
  <primary_completion_date type="Actual">June 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Rates of Substance Use</measure>
    <time_frame>Rates of substance use measured at 3 months</time_frame>
    <description>Percentage of days abstinent from alcohol use. Each person is followed for 3 months. For each person, we then calculate the number of days they were abstinent and the percentage of days abstinent (days abstinent/ all days in 3 months).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Psychiatric Symptoms</measure>
    <time_frame>Psychiatric symptoms measured at 3 months, 6 months, 12 months post randomization</time_frame>
    <description>3 month, 6 month and 12 month measures of psychiatric symptoms, as measured by the Brief Symptom Inventory (BSI). Minimum observed score was 22; maximum observed score was 110. Higher score is worse. Minimum score possible is 22. Maximum score possible is 110.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Health Related Quality of Life</measure>
    <time_frame>3 months, 6 months and 12 months after randomization</time_frame>
    <description>Physical and mental health subscales from the 12-item Medical Outcomes Study Short-form Health Survey, adapted for Veterans (VR-12). Observed scores on the MCS ranged from 2.89 to 70.39. Scores on the PCS ranged from 13.26 to 70.10. Higher scores denote better health. The minimum and maximum scores possible are 0 and 100, respectively.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">667</enrollment>
  <condition>Alcohol Dependence</condition>
  <condition>Drug Dependence</condition>
  <arm_group>
    <arm_group_label>Telephone Case Monitoring Aftercare</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Telephone Case Monitoring Aftercare</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Continuing Care as Usual</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Continuing Care as Usual</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Telephone Case Monitoring</intervention_name>
    <description>Telephone Case Monitoring involves telephone delivery of continuing care treatment post intensive outpatient SUD treatment. It includes brief weekly phone calls with a counselor for up to 6 months.</description>
    <arm_group_label>Telephone Case Monitoring Aftercare</arm_group_label>
    <other_name>TCM</other_name>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Continuing Care as Usual</intervention_name>
    <description>Continuing Care as Usual will include standard group outpatient SUD treatment.</description>
    <arm_group_label>Continuing Care as Usual</arm_group_label>
    <other_name>CCAU</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Participants will be recruited from all patients who complete at least 14 days of intensive
        outpatient (IOP) substance use disorder treatment over an 18-month period in 2 VA IOP SUD
        programs.

        Exclusion Criteria:

        Completion of less than 14 days of IOP treatment.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>John D. McKellar, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>VA Palo Alto Health Care System, Palo Alto, CA</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>VA Palo Alto Health Care System, Palo Alto, CA</name>
      <address>
        <city>Palo Alto</city>
        <state>California</state>
        <zip>94304-1290</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>VA Eastern Kansas Health Care System Colmery-O'Neil VA Medical Center, Topeka, KS</name>
      <address>
        <city>Topeka</city>
        <state>Kansas</state>
        <zip>66622</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Louis VA Medical Center John Cochran Division, St. Louis, MO</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63106</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>McKellar J, Wagner T, Harris A, Oehlert M, Buckley S, Moos R. One-year outcomes of telephone case monitoring for patients with substance use disorder. Addict Behav. 2012 Oct;37(10):1069-74. doi: 10.1016/j.addbeh.2012.03.009. Epub 2012 Mar 13.</citation>
    <PMID>22651986</PMID>
  </results_reference>
  <results_reference>
    <citation>Oser M, Cucciare M, McKellar J, Weingardt K. Correlates of hazardous drinking among Veterans with and without hepatitis C. J Behav Med. 2012 Dec;35(6):634-41. doi: 10.1007/s10865-011-9394-9. Epub 2012 Jan 11.</citation>
    <PMID>22234384</PMID>
  </results_reference>
  <results_reference>
    <citation>Austin J, McKellar JD, Moos R. The influence of co-occurring axis I disorders on treatment utilization and outcome in homeless patients with substance use disorders. Addict Behav. 2011 Sep;36(9):941-4. doi: 10.1016/j.addbeh.2011.05.001. Epub 2011 May 7.</citation>
    <PMID>21620571</PMID>
  </results_reference>
  <results_reference>
    <citation>Oser ML, McKellar J, Moos BS, Moos RH. Changes in ambivalence mediate the relation between entering treatment and change in alcohol use and problems. Addict Behav. 2010 Apr;35(4):367-9. doi: 10.1016/j.addbeh.2009.10.024. Epub 2009 Oct 30.</citation>
    <PMID>19926399</PMID>
  </results_reference>
  <results_reference>
    <citation>Barbosa PV, Thomas IC, Srinivas S, Buyyounouski MK, Chung BI, Chertow GM, Asch SM, Wagner TH, Brooks JD, Leppert JT. Overall Survival in Patients with Localized Prostate Cancer in the US Veterans Health Administration: Is PIVOT Generalizable? Eur Urol. 2016 Aug;70(2):227-30. doi: 10.1016/j.eururo.2016.02.037. Epub 2016 Mar 2.</citation>
    <PMID>26948397</PMID>
  </results_reference>
  <results_reference>
    <citation>Wagner TH, Burstin H, Frakt AB, Krein SL, Lorenz K, Maciejewski ML, Pizer SD, Weiner M, Yoon J, Zulman DM, Asch SM. Opportunities to Enhance Value-Related Research in the U.S. Department of Veterans Affairs. J Gen Intern Med. 2016 Apr;31 Suppl 1:78-83. doi: 10.1007/s11606-015-3538-5.</citation>
    <PMID>26951279</PMID>
  </results_reference>
  <results_reference>
    <citation>Gidwani R, Joyce N, Kinosian B, Faricy-Anderson K, Levy C, Miller SC, Ersek M, Wagner T, Mor V. Gap between Recommendations and Practice of Palliative Care and Hospice in Cancer Patients. J Palliat Med. 2016 Sep;19(9):957-63. doi: 10.1089/jpm.2015.0514. Epub 2016 May 26.</citation>
    <PMID>27228478</PMID>
  </results_reference>
  <verification_date>July 2018</verification_date>
  <study_first_submitted>December 12, 2005</study_first_submitted>
  <study_first_submitted_qc>December 12, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 14, 2005</study_first_posted>
  <results_first_submitted>October 2, 2014</results_first_submitted>
  <results_first_submitted_qc>October 16, 2014</results_first_submitted_qc>
  <results_first_posted type="Estimate">October 17, 2014</results_first_posted>
  <last_update_submitted>July 26, 2018</last_update_submitted>
  <last_update_submitted_qc>July 26, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 16, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Telemedicine</keyword>
  <keyword>Aftercare</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Alcoholism</mesh_term>
    <mesh_term>Substance-Related Disorders</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Telephone Case Monitoring Aftercare</title>
          <description>Telephone Case Monitoring: Telephone Case Monitoring involves telephone delivery of continuing care treatment post intensive outpatient SUD treatment. It includes brief weekly phone calls with a counselor for up to 6 months.</description>
        </group>
        <group group_id="P2">
          <title>Continuing Care as Usual</title>
          <description>Continuing Care as Usual: Continuing Care as Usual will include standard group outpatient SUD treatment.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="213"/>
                <participants group_id="P2" count="454"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="168"/>
                <participants group_id="P2" count="359"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="45"/>
                <participants group_id="P2" count="95"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Telephone Case Monitoring Aftercare</title>
          <description>Telephone Case Monitoring: Telephone Case Monitoring involves telephone delivery of continuing care treatment post intensive outpatient SUD treatment. It includes brief weekly phone calls with a counselor for up to 6 months.</description>
        </group>
        <group group_id="B2">
          <title>Continuing Care as Usual</title>
          <description>Continuing Care as Usual: Continuing Care as Usual will include standard group outpatient SUD treatment.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="213"/>
            <count group_id="B2" value="454"/>
            <count group_id="B3" value="667"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="51.9" spread="8.5"/>
                    <measurement group_id="B2" value="51.0" spread="8.1"/>
                    <measurement group_id="B3" value="51.3" spread="8.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="21"/>
                    <measurement group_id="B3" value="31"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="203"/>
                    <measurement group_id="B2" value="433"/>
                    <measurement group_id="B3" value="636"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Rates of Substance Use</title>
        <description>Percentage of days abstinent from alcohol use. Each person is followed for 3 months. For each person, we then calculate the number of days they were abstinent and the percentage of days abstinent (days abstinent/ all days in 3 months).</description>
        <time_frame>Rates of substance use measured at 3 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Telephone Case Monitoring Aftercare</title>
            <description>Telephone Case Monitoring: Telephone Case Monitoring involves telephone delivery of continuing care treatment post intensive outpatient SUD treatment. It includes brief weekly phone calls with a counselor for up to 6 months.</description>
          </group>
          <group group_id="O2">
            <title>Continuing Care as Usual</title>
            <description>Continuing Care as Usual: Continuing Care as Usual will include standard group outpatient SUD treatment.</description>
          </group>
        </group_list>
        <measure>
          <title>Rates of Substance Use</title>
          <description>Percentage of days abstinent from alcohol use. Each person is followed for 3 months. For each person, we then calculate the number of days they were abstinent and the percentage of days abstinent (days abstinent/ all days in 3 months).</description>
          <units>percentage of days</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="213"/>
                <count group_id="O2" value="454"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="91.1" spread="1.79"/>
                    <measurement group_id="O2" value="88.0" spread="1.81"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Psychiatric Symptoms</title>
        <description>3 month, 6 month and 12 month measures of psychiatric symptoms, as measured by the Brief Symptom Inventory (BSI). Minimum observed score was 22; maximum observed score was 110. Higher score is worse. Minimum score possible is 22. Maximum score possible is 110.</description>
        <time_frame>Psychiatric symptoms measured at 3 months, 6 months, 12 months post randomization</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Telephone Case Monitoring Aftercare</title>
            <description>Telephone Case Monitoring: Telephone Case Monitoring involves telephone delivery of continuing care treatment post intensive outpatient SUD treatment. It includes brief weekly phone calls with a counselor for up to 6 months.</description>
          </group>
          <group group_id="O2">
            <title>Continuing Care as Usual</title>
            <description>Continuing Care as Usual: Continuing Care as Usual will include standard group outpatient SUD treatment.</description>
          </group>
        </group_list>
        <measure>
          <title>Psychiatric Symptoms</title>
          <description>3 month, 6 month and 12 month measures of psychiatric symptoms, as measured by the Brief Symptom Inventory (BSI). Minimum observed score was 22; maximum observed score was 110. Higher score is worse. Minimum score possible is 22. Maximum score possible is 110.</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="213"/>
                <count group_id="O2" value="454"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>3 months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="47.22" spread="1.41"/>
                    <measurement group_id="O2" value="50.50" spread="1.00"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="49.76" spread="1.42"/>
                    <measurement group_id="O2" value="51.88" spread="1.02"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="48.79" spread="1.47"/>
                    <measurement group_id="O2" value="51.18" spread="1.07"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Health Related Quality of Life</title>
        <description>Physical and mental health subscales from the 12-item Medical Outcomes Study Short-form Health Survey, adapted for Veterans (VR-12). Observed scores on the MCS ranged from 2.89 to 70.39. Scores on the PCS ranged from 13.26 to 70.10. Higher scores denote better health. The minimum and maximum scores possible are 0 and 100, respectively.</description>
        <time_frame>3 months, 6 months and 12 months after randomization</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Telephone Case Monitoring Aftercare</title>
            <description>Telephone Case Monitoring: Telephone Case Monitoring involves telephone delivery of continuing care treatment post intensive outpatient SUD treatment. It includes brief weekly phone calls with a counselor for up to 6 months.</description>
          </group>
          <group group_id="O2">
            <title>Continuing Care as Usual</title>
            <description>Continuing Care as Usual: Continuing Care as Usual will include standard group outpatient SUD treatment.</description>
          </group>
        </group_list>
        <measure>
          <title>Health Related Quality of Life</title>
          <description>Physical and mental health subscales from the 12-item Medical Outcomes Study Short-form Health Survey, adapted for Veterans (VR-12). Observed scores on the MCS ranged from 2.89 to 70.39. Scores on the PCS ranged from 13.26 to 70.10. Higher scores denote better health. The minimum and maximum scores possible are 0 and 100, respectively.</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="209"/>
                <count group_id="O2" value="443"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>3 month PCS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="45.64" spread=".83"/>
                    <measurement group_id="O2" value="44.92" spread=".57"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 month PCS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="44.54" spread=".96"/>
                    <measurement group_id="O2" value="43.58" spread=".66"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 month PCS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="43.37" spread=".91"/>
                    <measurement group_id="O2" value="42.72" spread=".66"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 month MCS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="36.22" spread=".81"/>
                    <measurement group_id="O2" value="35.13" spread=".57"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 month MCS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="40.81" spread="1.02"/>
                    <measurement group_id="O2" value="39.09" spread=".66"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 month MCS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="40.72" spread=".94"/>
                    <measurement group_id="O2" value="40.12" spread=".69"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <desc>Serious Adverse Events were tracked. There was no tracking of other adverse events.</desc>
      <group_list>
        <group group_id="E1">
          <title>Telephone Case Monitoring Aftercare</title>
          <description>Telephone Case Monitoring: Telephone Case Monitoring involves telephone delivery of continuing care treatment post intensive outpatient SUD treatment. It includes brief weekly phone calls with a counselor for up to 6 months.
SAEs were tracked, but AEs were not tracked.</description>
        </group>
        <group group_id="E2">
          <title>Continuing Care as Usual</title>
          <description>Continuing Care as Usual: Continuing Care as Usual will include standard group outpatient SUD treatment.
SAEs were tracked, but AEs were not tracked.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="213"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="454"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="60" subjects_at_risk="213"/>
                <counts group_id="E2" subjects_affected="92" subjects_at_risk="454"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>hosapitalizations</sub_title>
                <counts group_id="E1" events="102" subjects_affected="60" subjects_at_risk="213"/>
                <counts group_id="E2" events="206" subjects_affected="92" subjects_at_risk="454"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Todd Wagner</name_or_title>
      <organization>VA Center for Innovation to Implementation</organization>
      <phone>6504935000 ext 22048</phone>
      <email>todd.wagner@va.gov</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

